BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34783573)

  • 1. Evaluation of Copper-64-Labeled α
    Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
    Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
    Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
    Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
    Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
    J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of
    Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
    J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Evans Blue and 4-(
    Davis RA; Hausner SH; Harris R; Sutcliffe JL
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.
    Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL
    Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ImmunoPET Imaging of α
    White JB; Hu LY; Boucher DL; Sutcliffe JL
    Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6.
    Hu LY; Bauer N; Knight LM; Li Z; Liu S; Anderson CJ; Conti PS; Sutcliffe JL
    Mol Imaging Biol; 2014 Aug; 16(4):567-77. PubMed ID: 24448825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Translation of a
    Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
    J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Two Optical Probes for Imaging the Integrin α
    Ganguly T; Tang SY; Bauer N; Sutcliffe JL
    Mol Imaging Biol; 2020 Oct; 22(5):1170-1181. PubMed ID: 32002763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
    Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
    J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of a Monomethyl Auristatin E─Integrin α
    Davis RA; Ganguly T; Harris R; Hausner SH; Kovacs L; Sutcliffe JL
    J Med Chem; 2023 Jul; 66(14):9842-9852. PubMed ID: 37417540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
    Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect.
    Singh AN; McGuire MJ; Li S; Hao G; Kumar A; Sun X; Brown KC
    Theranostics; 2014; 4(7):745-60. PubMed ID: 24883124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an integrin αvβ6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry.
    Hausner SH; Carpenter RD; Bauer N; Sutcliffe JL
    Nucl Med Biol; 2013 Feb; 40(2):233-9. PubMed ID: 23265667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
    Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
    Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT Imaging of NSCLC with a α
    Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
    Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.
    White JB; Boucher DL; Zettlitz KA; Wu AM; Sutcliffe JL
    Nucl Med Biol; 2015 Dec; 42(12):945-57. PubMed ID: 26341848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.